TrueSight
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
TrueSight - overview
Established
2018
Location
Beijing, -, China
Primary Industry
Medical Devices & Equipment
About
Established in 2018 and based in Beijing, Chian, Hubei Jingzhen Medical Technology Co. , Ltd. , trading as TrueSight, operates as a digital precision surgery technology solution provider that focuses on medical image artificial intelligence research. The company cooperates with Qinghua University School Of Medicine, Xidian University and Zhongnan Hospital Of Wuhan University.
In February 2026, TrueSight raised a series B+ funding from new investor Wuhan Wuchuangyuan Investment. The company provides medical intelligent image technology solutions for medical industry and patients. The product of the company includes TrueSight, TrueView, TrueTrace and new coronary pneumonia AI intelligent clinical aided analysis system. The company adopts artificial intelligence algorithm.
The company's revenue is generated by providing digital precision surgery technology solution and automated 3D liver reconstruction systems. The company will use the series B+ funding to further promote its research and application in the field of medical intelligent imaging technology.
Current Investors
ZhenFund, Y&R Capital, Changfeng Hengchuang Venture
Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare, Medical Devices & Equipment
Website
www.truesight.com
Verticals
Artificial Intelligence, HealthTech
Company Stage
Series B
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.